08 Nov 2019
EECP is a non-invasive, US-FDA approved treatment modality which can be used at any age, at any time, by all patients suffering from refractory Angina before or after coronary angioplasty or bypass operation.
- Patient who are not eligible for Angioplasty or bypass operation
- Patients who have undergone Angioplasty or bypass opertaion, but there are reblockages in stents or grafts
- Patients who are suffering from severe Kidney, Liver or Lung disease and are ineligible for invasive procedures